27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- Turning Point Brands Inc (NYSE:TPB) stated that the Food and Drug Administration (FDA) had rescinded its September 14 Marketing Denial Order (MDO) for certain of its vapor products with pending Premarket Tobacco Product Applications (MTAs) under review.
- All of TPB's proprietary vapor products, including its Solace branded e-liquids, will continue to be marketed while they remain under review.
- "We are encouraged by the FDA's decision to reconsider our product applications and look forward to engaging the agency as our PMTAs are reviewed," said CEO Larry Wexler.
- In response to the September 14 MDO, the company had filed a petition for relief and motion to stay the decision in the 6th Circuit Court of Appeals. On October 8, due to the rescission letter, TPB withdrew both the petition and motion.
- Price Action: TPB shares are trading higher by 2.58% at $49.25 in premarket on the last check Monday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!